These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3932304)

  • 1. Evolution and present situation of Staphylococcus aureus sensitivity to MLS in hospital (1975-83).
    Thabaut A; Meyran M; Huerre M
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():205-7. PubMed ID: 3932304
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative evaluation of macrolides, lincosamides and streptogramins in staphylococcal infections.
    Modai J
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():195-7. PubMed ID: 3932302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypes of staphylococcal resistance to macrolides, lincosamides and streptogramin B (MLS) in a Turkish university hospital.
    Tunçkanat F; Arikan S
    Zentralbl Bakteriol; 2000 Jan; 289(8):827-33. PubMed ID: 10705614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution and epidemiology of MLS resistance.
    Duval J
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():137-49. PubMed ID: 3932300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Resistance to macrolides, lincosamides and streptogramins in infections by Streptococcus pneumoniae].
    Alonso Manzanares MA; Gutíerrez Zufiaurre MN; Muñoz Bellido JL; García-Rodríguez JA
    Med Clin (Barc); 1998 Feb; 110 Suppl 1():25-30. PubMed ID: 9717157
    [No Abstract]   [Full Text] [Related]  

  • 6. Should clindamycin be used as treatment of patients with infections caused by erythromycin-resistant staphylococci?
    Panagea S; Perry JD; Gould FK
    J Antimicrob Chemother; 1999 Oct; 44(4):581-2. PubMed ID: 10588329
    [No Abstract]   [Full Text] [Related]  

  • 7. Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.
    Zarrouk V; Bozdogan B; Leclercq R; Garry L; Feger C; Carbon C; Fantin B
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1244-8. PubMed ID: 11257041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of macrolide, lincosamide, and streptogramin resistance among staphylococci in a tertiary care hospital in Athens, Greece.
    Vallianou N; Evangelopoulos A; Hadjisoteriou M; Avlami A; Petrikkos G
    J Chemother; 2015; 27(6):319-23. PubMed ID: 25112954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Staphylomycin sensitivity of staphylococci in the in-vitro test].
    Paetzold OH
    Hautarzt; 1967 Oct; 18(10):464-8. PubMed ID: 4874188
    [No Abstract]   [Full Text] [Related]  

  • 10. Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria.
    Leclercq R; Courvalin P
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1273-6. PubMed ID: 1929281
    [No Abstract]   [Full Text] [Related]  

  • 11. Inducible resistance to macrolides, lincosamides and streptogramin type B antibiotics: the resistance phenotype, its biological diversity, and structural elements that regulate expression--a review.
    Weisblum B
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():63-90. PubMed ID: 3932311
    [No Abstract]   [Full Text] [Related]  

  • 12. Resistance issues and treatment implications: pneumococcus, Staphylococcus aureus, and gram-negative rods.
    Low DE
    Infect Dis Clin North Am; 1998 Sep; 12(3):613-30, viii. PubMed ID: 9779381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of genes encoding resistance to macrolides, lincosamides and streptogramins among clinical staphylococcal isolates in a Turkish university hospital.
    Cetin ES; Gunes H; Kaya S; Aridogan BC; Demirci M
    J Microbiol Immunol Infect; 2010 Dec; 43(6):524-9. PubMed ID: 21195981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bacteriological studies on staphylomycin].
    Nakazawa S; Yokota Y; Ueda Y; Shiraishi K; Akiba A
    Jpn J Antibiot; 1968 Feb; 21(1):15-8. PubMed ID: 4875184
    [No Abstract]   [Full Text] [Related]  

  • 15. [Staphylococcus aureus in the hospital milieu].
    Larabi K; Abouda H; Fendri C; Ben Rachid MS
    Arch Inst Pasteur Tunis; 1992; 69(3-4):283-92. PubMed ID: 1341138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological study of an outbreak of infection with Staphylococcus aureus resistant to lincosamides and streptogramin A in a French hospital.
    Arpin C; Lagrange I; Gachie JP; Bebear C; Quentin C
    J Med Microbiol; 1996 Apr; 44(4):303-10. PubMed ID: 8606359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dyadic plasmid that shows MLS and PMS resistance in Staphylococcus aureus.
    Matsuoka M; Endou K; Kobayashi H; Inoue M; Nakajima Y
    FEMS Microbiol Lett; 1997 Mar; 148(1):91-6. PubMed ID: 9066116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Selection of constitutive mutants of gram-positive cocci inducible resistant to macrolides, lincosamides and streptogramins (MLS): comparison of the selective effects of the MLS].
    Leclercq R; Bauduret F; Soussy CJ
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):568-72. PubMed ID: 2508040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MLS resistance phenotypes and mechanisms in beta-haemolytic group B, C and G Streptococcus isolates in La Rioja, Spain.
    Portillo A; Lantero M; Olarte I; Ruiz-Larrea F; Torres C
    J Antimicrob Chemother; 2001 Jan; 47(1):115-6. PubMed ID: 11152443
    [No Abstract]   [Full Text] [Related]  

  • 20. Macrolide-lincosamide-streptogramin B (MLS) resistance in cutaneous propionibacteria: definition of phenotypes.
    Eady EA; Ross JI; Cove JH; Holland KT; Cunliffe WJ
    J Antimicrob Chemother; 1989 Apr; 23(4):493-502. PubMed ID: 2501269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.